These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 10401760)

  • 21. Role of endothelin-converting enzyme in the systemic hemodynamics and regional circulatory effects of proendothelin-1 (1-38) and diaspirin cross-linked hemoglobin in rats.
    Gulati A; Singh R; Chung SM; Sen AP
    J Lab Clin Med; 1995 Dec; 126(6):559-70. PubMed ID: 7490515
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endothelin-1, endothelin-3 and their receptors (endothelin(A) and endothelin(B)) in chronic renal transplant rejection in rats.
    Deng DX; Jiang J; Garcia B; Zhong R; Chakrabarti S
    Transpl Int; 2000; 13(3):175-82. PubMed ID: 10935699
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New approach in the therapy of chronic rejection? ACE- and AT1-blocker reduce the development of chronic rejection after cardiac transplantation in a rat model.
    Richter M; Skupin M; Grabs R; Schramm D; Richter H; Olbrich HG
    J Heart Lung Transplant; 2000 Nov; 19(11):1047-55. PubMed ID: 11077221
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of inhibition of poly(adenosine diphosphate-ribose) synthase on acute cardiac allograft rejection.
    Liu Y; Son NH; Szabolcs MJ; Ma N; Sciacca RR; Albala A; Edwards N; Cannon PJ
    Transplantation; 2004 Sep; 78(5):668-74. PubMed ID: 15371666
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Initial T-cell activation required for transplant vasculopathy in retransplanted rat cardiac allografts.
    Tori M; Kitagawa-Sakakida S; Li Z; Izutani H; Horiguchi K; Ito T; Matsuda H; Shirakura R
    Transplantation; 2000 Sep; 70(5):737-46. PubMed ID: 11003350
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diltiazem preserves direct vasodilator response but fails to suppress intimal proliferation in rat allograft coronary artery disease.
    Takami H; Backer CL; Crawford SE; Pahl E; Mavroudis C
    J Heart Lung Transplant; 1996 Jan; 15(1 Pt 1):67-77. PubMed ID: 8820085
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cyclosporin A does not enhance the development of transplant vasculopathy: experimental study in a rat cardiac transplant model.
    Richter MH; Richter H; Barten M; Schramm D; Weinert M; Gummert J; Mohr FW; Olbrich HG
    Transplant Proc; 2002 Aug; 34(5):1479-80. PubMed ID: 12176448
    [No Abstract]   [Full Text] [Related]  

  • 28. Comparison of rapamycin, RS 61443, cyclosporine, and low-dose heparin as treatment for transplant vasculopathy in a rat model of chronic allograft rejection.
    Schmid C; Heemann U; Azuma H; Tilney NL
    Transplant Proc; 1995 Feb; 27(1):438-9. PubMed ID: 7879053
    [No Abstract]   [Full Text] [Related]  

  • 29. Combination treatment with an ET(A)-receptor blocker and an ACE inhibitor is not superior to the respective monotherapies in attenuating chronic transplant vasculopathy in different aorta allotransplantation rat models.
    Orth SR; Odoni G; Karkoszka H; Ogata H; Viedt C; Amann K; Ferrari P; Ritz E
    Nephrol Dial Transplant; 2003 Jan; 18(1):62-9. PubMed ID: 12480961
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Histological characterization and pharmacological control of chronic rejection in xenogeneic and allogeneic heart transplantation.
    Shen J; Chong AS; Xiao F; Liu W; Huang W; Blinder L; Foster P; Sankary H; Jensik S; McChesney L; Mital D; Williams JW
    Transplantation; 1998 Sep; 66(6):692-8. PubMed ID: 9771831
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intrathymic injection of donor-specific X-irradiation-sensitive spleen cells abrogates accelerated rejection of cardiac allografts in sensitized rats.
    Binder J; Sayegh MH; Watschinger B; Hancock WW; Kupiec-Weglinski JW
    Transplantation; 1994 Jul; 58(1):80-6. PubMed ID: 8036712
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevention of chronic rejection by pravastatin in a rat kidney transplant model.
    Ji P; Si MS; Podnos Y; Chow H; Steward E; Imagawa DK
    Transplantation; 2002 Sep; 74(6):821-7. PubMed ID: 12364863
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Validation of Donor-Specific Tolerance of Intestinal Transplant by a Secondary Heart Transplantation Model.
    Pengcheng W; Xiaosong L; Xiaofeng L; Zhongzhi L
    Exp Clin Transplant; 2017 Feb; 15(1):89-95. PubMed ID: 28122485
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tolerance induced by bone marrow chimerism prevents transplant vascular sclerosis in a rat model of small bowel transplant chronic rejection.
    Orloff SL; Yin Q; Corless CL; Orloff MS; Rabkin JM; Wagner CR
    Transplantation; 2000 Apr; 69(7):1295-303. PubMed ID: 10798744
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Induction of donor-specific tolerance to cardiac but not skin or renal allografts by intrathymic injection of splenocyte alloantigen.
    Nakafusa Y; Goss JA; Mohanakumar T; Flye MW
    Transplantation; 1993 Apr; 55(4):877-82. PubMed ID: 8475563
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [D-Val22]big ET-1[16-38] inhibits endothelin-converting enzyme activity: a promising concept in the prevention of cerebral vasospasm.
    Zimmermann M; Jung CS; Vatter H; Raabe A; Seifert V
    Neurosurg Rev; 2003 May; 26(2):125-32. PubMed ID: 12962299
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The specific monocarboxylate transporter-1 (MCT-1) inhibitor, AR-C117977, induces donor-specific suppression, reducing acute and chronic allograft rejection in the rat.
    Ekberg H; Qi Z; Pahlman C; Veress B; Bundick RV; Craggs RI; Holness E; Edwards S; Murray CM; Ferguson D; Kerry PJ; Wilson E; Donald DK
    Transplantation; 2007 Nov; 84(9):1191-9. PubMed ID: 17998876
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hyperhomocyst(e)inemia induces accelerated transplant vascular sclerosis in syngeneic and allogeneic rat cardiac transplants.
    Cook JW; Yin Q; Malinow MR; Orloff SL
    Am J Transplant; 2002 Mar; 2(3):244-51. PubMed ID: 12096787
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of chronic renal allograft rejection in rats with a low-molecular-weight heparin (reviparin).
    Braun C; Schultz M; Fang L; Schaub M; Back WE; Herr D; Laux V; Rohmeiss P; Schnuelle P; van der Woude FJ
    Transplantation; 2001 Jul; 72(2):209-15. PubMed ID: 11477340
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of single-dose rapamycin-based immunosuppression on the development of cardiac allograft vasculopathy.
    Goggins WC; Fisher RA; Cohen DS; Tawes JW; Grimes MM
    J Heart Lung Transplant; 1996 Aug; 15(8):790-5. PubMed ID: 8878761
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.